Mandate

Vinge advises Adelis Equity Partners on the establishment of Adelis Equity Partners Fund IV

March 03, 2025 Private Funds

Vinge has advised Adelis Equity Partners on the establishment of Adelis’ fourth flagship fund: Adelis Equity Partners Fund IV.

The fund, which was significantly oversubscribed, held its final closing on 28 February 2025 after having raised commitments of EUR 1.6 billion from an investor base consisting of leading pension funds, foundations and fund-of-funds across Europe and North America, and from the Adelis team. The fund raise entails a more than 50% increase in commitments relative to the predecessor fund, Adelis Equity Partners Fund III. Since its commencement in 2013, Adelis invests in well-positioned companies in the Nordic and DACH regions and has to date made 45 platform investments and more than 260 add-on acquisitions.

Vinge’s team primarily consisted of Mattias Schömer, Nils Unckel, Martin Cronsioe, Ulf Nilsson, Mikaela Reinhammar, Anton Sjökvist, Emelie Svanberg, Tobias Onegård Karlsson, Viktoria Wnuk, Rebecka Margolin, Saga Meyer Viklund and Emelie Zingmark.

Related

Vinge advises Consolid Equity in connection with the establishment of Petra Group

Vinge has advised Consolid Equity Investment AB ("Consolid Equity") on the acquisition of Ström & Gulliksson, one of the leading patent agencies in the Nordics. The acquisition forms part of the establishment of Petra Group, a European platform aimed at consolidating patent agencies across Europe to combine expertise and resources primarily within patents and trademarks. Consolid acts as a strategic partner in the new group.
July 08, 2026

Vinge has advised Scandic on new credit facilities with SEK 7.5 billion credit facilities

Vinge has represented Scandic Hotels Group AB (publ) in connection with a facilities agreement for SEK 7,500,000,000 with a syndicate of banks, arranged by DNB Carnegie Investment Bank AB and Nordea Bank Abp, filial i Sverige.
July 08, 2026

Vinge has advised Vitamin Well and its majority shareholders Cinven, Bridgepoint and the founders on Vitamin Well's combination with EMPWR

Vinge has advised Vitamin Well and its majority shareholders Cinven, the founders of Vitamin Well and Bridgepoint on Vitamin Well's acquisition of EMPWR Nutrition Group from majority seller Waterland Private Equity Investments.
July 03, 2026